Skip to main content

AGMB · AgomAb Therapeutics NV · Off Exchange

Track AGMB — free
$8.90 +0.67 (+8.14%)
Market Cap
$433.38M
Shares
49.25M
Volume · Oct 20 20.24K Avg daily vol (3M) 137.42K

Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.

Off-Exchange Volume History

Week Start ATS Volume Non-ATS OTC Volume Total Off-Exchange % of FINRA Weekly Volume
2026-09-14 271,261 215,465 486,726 51.6%
2026-09-07 147,192 77,101 224,293 35.2%
2026-08-31 334,181 398,158 732,339 63.2%
2026-08-24 276,908 171,681 448,589 49.7%
2026-08-17 176,699 43,261 219,960 49.1%
2026-08-10 292,362 49,230 341,592 58.5%
2026-08-03 177,537 257,296 434,833 67.0%
2026-07-27 70,525 33,659 104,184 44.1%
2026-07-20 103,167 101,919 205,086 48.1%
2026-07-13 67,056 129,805 196,861 45.6%
2026-07-06 86,395 60,616 147,011 41.8%
2026-06-29 88,687 90,131 178,818 26.7%
2026-06-22 122,232 147,890 270,122 47.4%
2026-06-15 169,938 112,102 282,040 49.7%
2026-06-08 266,268 160,456 426,724 56.9%
2026-06-01 109,640 146,546 256,186 64.8%
2026-05-25 39,306 72,047 111,353 56.4%
2026-05-18 60,732 28,810 89,542 46.2%
2026-05-11 79,249 124,756 204,005 47.8%
2026-05-04 93,694 152,643 246,337 51.9%
2026-04-27 72,737 116,030 188,767 37.3%
2026-04-20 65,540 177,195 242,735 36.9%
2026-04-13 155,901 597,316 753,217 53.8%
2026-04-06 204,536 278,854 483,390 59.6%
2026-03-30 47,700 618,884 666,584 49.5%
2026-03-23 152,030 350,222 502,252 56.6%
2026-03-16 187,974 272,233 460,207 51.5%
2026-03-09 58,205 47,689 105,894 31.8%
2026-03-02 113,784 79,369 193,153 37.6%
2026-02-23 111,761 40,773 152,534 26.5%
2026-02-16 146,387 56,298 202,685 26.1%
2026-02-09 178,831 305,595 484,426 33.3%
2026-02-02 543,366 114,333 657,699 27.8%
Showing 1–33 of 33 weeks
Key facts CIK 2020932 CUSIP 00860C102 13F (30d) 2 filings 2 filers Visit website Investor relations